CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. Soft agarose colony assay of parental P19 cells, the clone transfected with empty vector (Mock), and Evi1-transfected P19 cells (clones D2 and D5). A, numbers of colony formation for the parental P19 cells and transformants. Columns, numbers of colonies in each dish; bars, SD. B, micrography of wild-type P19 cells (Ba), wild-type P19 cells 4 days after RA treatment (day 4; Bb), vector-transformant P19 clone (mock; Bc), and Evi1-transformant clones D2 (Bd) grown in the soft agarose after 10 days. C, growth curve of control P19 cells, vector-transfected cells (mock), and Evi1-transfected clones (D2 and D5). Cells (1 x 104 cells/ml) were seeded in 2 ml of culture medium in individual wells of six-well plates. At each indicated time point, cell viability was determined. Data points, mean cell numbers per triplicate wells, plotted against the number of days after seeding; bars, SD. {blacksquare}, P19; •, mock; {circ}, D2; {blacktriangleup}, D5.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation